Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.45 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.45 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | ALOX5 | P09917 | 4/20 | 0.35 |
| ▸ | SRC | P12931 | 2/20 | 0.34 |
| ▸ | NUAK1 | O60285 | 1/20 | 0.34 |
| ▸ | IGF1R | P08069 | 1/20 | 0.34 |
| ▸ | MET | P08581 | 1/20 | 0.34 |
| ▸ | PIM1 | P11309 | 1/20 | 0.34 |
| ▸ | AXL | P30530 | 1/20 | 0.34 |
| ▸ | AKT1 | P31749 | 1/20 | 0.34 |
| ▸ | KDR | P35968 | 1/20 | 0.34 |
| ▸ | NEK2 | P51955 | 1/20 | 0.34 |
| ▸ | PLK1 | P53350 | 1/20 | 0.34 |
| ▸ | PTK2 | Q05397 | 1/20 | 0.34 |
| ▸ | PKN1 | Q16512 | 1/20 | 0.34 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.34 |
| ▸ | NEK6 | Q9HC98 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12465650 | 0.84 | TSHR (0.33) | TSHRPTGS1PTGS2CYP1A2CYP3A4 | |
| SCHEMBL3145048 | 0.80 | PTGS1 (0.44) | TSHRPTGS1PTGS2CYP1A2CYP3A4 | |
| SCHEMBL23421679 | 0.78 | PTGS2 (0.45) | TSHRPTGS1PTGS2SRCNUAK1 | |
| SCHEMBL13592921 | 0.77 | PTGS1 (0.41) | TSHRPTGS1PTGS2CYP1A2CYP3A4 | |
| SCHEMBL6906681 | 0.73 | ALOX5 (0.41) | TSHRPTGS1PTGS2CYP1A2CYP3A4 | |
| SCHEMBL14026631 | 0.69 | KDM4E (0.38) | TSHRCYP1A2CYP2C9CYP2C19 | |
| SCHEMBL4466134 | 0.68 | — | — | |
| SCHEMBL9197687 | 0.68 | PTGS2 (0.40) | PTGS1PTGS2SRCNUAK1IGF1R | |
| SCHEMBL10058464 | 0.67 | AKT1 (0.39) | TSHRCYP3A4ALOX5AKT1MAPT | |
| SCHEMBL13431163 | 0.67 | ALOX5 (0.36) | TSHRPTGS1PTGS2CYP1A2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025237521-A1 | A NOVEL WATER-PROCESSABLE N-TYPE CONDUCTING POLYMER | WESTRA MATERIALS AB (SE) | 2025-11-20 | — | — | WO | disclosed |
| EP-4630472-A1 | A METHOD FOR OBTAINING A WATER-PROCESSABLE N-TYPE CONDUCTING POLYMER | Westra Materials AB (SE) | 2025-10-15 | — | — | EP | disclosed |
| WO-2024165720-A1 | A METHOD FOR OBTAINING A WATER-PROCESSABLE N-TYPE CONDUCTING POLYMER | N-INK AB (SE) | 2024-08-15 | — | — | WO | disclosed |
| WO-2021106947-A1 | NOVEL QUINONE DERIVATIVE AND ANTITRYPANOSOMAL AGENT CONTAINING SAME AS ACTIVE INGREDIENT | 国立大学法人群馬大学 | 2021-06-03 | — | — | WO | disclosed |
| WO-2012105857-A1 | GEL ACTUATOR | UNIVERSITY OF OTAGO (NZ) | 2012-08-09 | — | — | WO | disclosed |
| US-7576094-B2 | Spiro derivatives as lipoxygenase inhibitors | ELI LILLY AND COMPANY (US) | 2009-08-18 | — | — | US | disclosed |
| EP-1836183-A2 | SPIRO DERIVATIVES AS LIPOXYGENASE INHIBITORS | Galileo Pharmaceuticals, Inc. (US) | 2007-09-26 | — | — | EP | disclosed |
| WO-2006065686-A2 | SPIRO DERIVATIVES AS LIPOXYGENASE INHIBITORS | GALILEO PHARMACEUTICALS, INC. (US) | 2006-06-22 | — | — | WO | disclosed |
| US-20060128790-A1 | Spiro derivatives as lipoxygenase inhibitors | GALILEO PHARMACEUTICALS, INC. | 2006-06-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060128790-A1 | Spiro derivatives as lipoxygenase inhibitors | ALOX15B, ALOX5, ALOX15 | TSHR 2301/4885PTGS1 24/4885PTGS2 34/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.